Global DNA-encoded Chemical Libraries (DEL) Market Research Report 2025

Publication ID:

PB504250563

Publication Date:

April 28, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for DNA-encoded Chemical Libraries (DEL) was valued at US$ 210 million in the year 2024 and is projected to reach a revised size of US$ 400 million by 2031, growing at a CAGR of 9.8% during the forecast period.
DNA-encoded chemical libraries (DELs) represent a versatile and powerful technology platform for the discovery of small-molecule ligands to protein targets of biological and pharmaceutical interest. DELs are collections of molecules, individually coupled to distinctive DNA tags serving as amplifiable identification barcodes.
North American market for DNA-encoded Chemical Libraries (DEL) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for DNA-encoded Chemical Libraries (DEL) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for DNA-encoded Chemical Libraries (DEL) in Pharmaceutical and Biotechnology Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of DNA-encoded Chemical Libraries (DEL) include HotSpot Therapeutics, X-Chem, Amgen, Life Chemicals, Elsevier, NovAliX, BOC Sciences, DECLTechnology, Serengen, BioDuro-Sundia, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for DNA-encoded Chemical Libraries (DEL), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA-encoded Chemical Libraries (DEL).
The DNA-encoded Chemical Libraries (DEL) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA-encoded Chemical Libraries (DEL) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA-encoded Chemical Libraries (DEL) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
HotSpot Therapeutics
X-Chem
Amgen
Life Chemicals
Elsevier
NovAliX
BOC Sciences
DECLTechnology
Serengen
BioDuro-Sundia
Novartis
DyNAbind
HitGen
PharmaBlock Sciences
WuXi AppTec
GenScript
Pharmaron
Segment by Type
Single-pharmacophore
Dual-pharmacophore
Segment by Application
Pharmaceutical and Biotechnology Companies
Research Laboratories
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of DNA-encoded Chemical Libraries (DEL) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA-encoded Chemical Libraries (DEL) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Single-pharmacophore
1.2.3 Dual-pharmacophore
1.3 Market by Application
1.3.1 Global DNA-encoded Chemical Libraries (DEL) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA-encoded Chemical Libraries (DEL) Market Perspective (2020-2031)
2.2 Global DNA-encoded Chemical Libraries (DEL) Growth Trends by Region
2.2.1 Global DNA-encoded Chemical Libraries (DEL) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 DNA-encoded Chemical Libraries (DEL) Historic Market Size by Region (2020-2025)
2.2.3 DNA-encoded Chemical Libraries (DEL) Forecasted Market Size by Region (2026-2031)
2.3 DNA-encoded Chemical Libraries (DEL) Market Dynamics
2.3.1 DNA-encoded Chemical Libraries (DEL) Industry Trends
2.3.2 DNA-encoded Chemical Libraries (DEL) Market Drivers
2.3.3 DNA-encoded Chemical Libraries (DEL) Market Challenges
2.3.4 DNA-encoded Chemical Libraries (DEL) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA-encoded Chemical Libraries (DEL) Players by Revenue
3.1.1 Global Top DNA-encoded Chemical Libraries (DEL) Players by Revenue (2020-2025)
3.1.2 Global DNA-encoded Chemical Libraries (DEL) Revenue Market Share by Players (2020-2025)
3.2 Global DNA-encoded Chemical Libraries (DEL) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by DNA-encoded Chemical Libraries (DEL) Revenue
3.4 Global DNA-encoded Chemical Libraries (DEL) Market Concentration Ratio
3.4.1 Global DNA-encoded Chemical Libraries (DEL) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA-encoded Chemical Libraries (DEL) Revenue in 2024
3.5 Global Key Players of DNA-encoded Chemical Libraries (DEL) Head office and Area Served
3.6 Global Key Players of DNA-encoded Chemical Libraries (DEL), Product and Application
3.7 Global Key Players of DNA-encoded Chemical Libraries (DEL), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA-encoded Chemical Libraries (DEL) Breakdown Data by Type
4.1 Global DNA-encoded Chemical Libraries (DEL) Historic Market Size by Type (2020-2025)
4.2 Global DNA-encoded Chemical Libraries (DEL) Forecasted Market Size by Type (2026-2031)
5 DNA-encoded Chemical Libraries (DEL) Breakdown Data by Application
5.1 Global DNA-encoded Chemical Libraries (DEL) Historic Market Size by Application (2020-2025)
5.2 Global DNA-encoded Chemical Libraries (DEL) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America DNA-encoded Chemical Libraries (DEL) Market Size (2020-2031)
6.2 North America DNA-encoded Chemical Libraries (DEL) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America DNA-encoded Chemical Libraries (DEL) Market Size by Country (2020-2025)
6.4 North America DNA-encoded Chemical Libraries (DEL) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DNA-encoded Chemical Libraries (DEL) Market Size (2020-2031)
7.2 Europe DNA-encoded Chemical Libraries (DEL) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe DNA-encoded Chemical Libraries (DEL) Market Size by Country (2020-2025)
7.4 Europe DNA-encoded Chemical Libraries (DEL) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA-encoded Chemical Libraries (DEL) Market Size (2020-2031)
8.2 Asia-Pacific DNA-encoded Chemical Libraries (DEL) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific DNA-encoded Chemical Libraries (DEL) Market Size by Region (2020-2025)
8.4 Asia-Pacific DNA-encoded Chemical Libraries (DEL) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DNA-encoded Chemical Libraries (DEL) Market Size (2020-2031)
9.2 Latin America DNA-encoded Chemical Libraries (DEL) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America DNA-encoded Chemical Libraries (DEL) Market Size by Country (2020-2025)
9.4 Latin America DNA-encoded Chemical Libraries (DEL) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA-encoded Chemical Libraries (DEL) Market Size (2020-2031)
10.2 Middle East & Africa DNA-encoded Chemical Libraries (DEL) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa DNA-encoded Chemical Libraries (DEL) Market Size by Country (2020-2025)
10.4 Middle East & Africa DNA-encoded Chemical Libraries (DEL) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 HotSpot Therapeutics
11.1.1 HotSpot Therapeutics Company Details
11.1.2 HotSpot Therapeutics Business Overview
11.1.3 HotSpot Therapeutics DNA-encoded Chemical Libraries (DEL) Introduction
11.1.4 HotSpot Therapeutics Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.1.5 HotSpot Therapeutics Recent Development
11.2 X-Chem
11.2.1 X-Chem Company Details
11.2.2 X-Chem Business Overview
11.2.3 X-Chem DNA-encoded Chemical Libraries (DEL) Introduction
11.2.4 X-Chem Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.2.5 X-Chem Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen DNA-encoded Chemical Libraries (DEL) Introduction
11.3.4 Amgen Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.3.5 Amgen Recent Development
11.4 Life Chemicals
11.4.1 Life Chemicals Company Details
11.4.2 Life Chemicals Business Overview
11.4.3 Life Chemicals DNA-encoded Chemical Libraries (DEL) Introduction
11.4.4 Life Chemicals Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.4.5 Life Chemicals Recent Development
11.5 Elsevier
11.5.1 Elsevier Company Details
11.5.2 Elsevier Business Overview
11.5.3 Elsevier DNA-encoded Chemical Libraries (DEL) Introduction
11.5.4 Elsevier Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.5.5 Elsevier Recent Development
11.6 NovAliX
11.6.1 NovAliX Company Details
11.6.2 NovAliX Business Overview
11.6.3 NovAliX DNA-encoded Chemical Libraries (DEL) Introduction
11.6.4 NovAliX Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.6.5 NovAliX Recent Development
11.7 BOC Sciences
11.7.1 BOC Sciences Company Details
11.7.2 BOC Sciences Business Overview
11.7.3 BOC Sciences DNA-encoded Chemical Libraries (DEL) Introduction
11.7.4 BOC Sciences Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.7.5 BOC Sciences Recent Development
11.8 DECLTechnology
11.8.1 DECLTechnology Company Details
11.8.2 DECLTechnology Business Overview
11.8.3 DECLTechnology DNA-encoded Chemical Libraries (DEL) Introduction
11.8.4 DECLTechnology Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.8.5 DECLTechnology Recent Development
11.9 Serengen
11.9.1 Serengen Company Details
11.9.2 Serengen Business Overview
11.9.3 Serengen DNA-encoded Chemical Libraries (DEL) Introduction
11.9.4 Serengen Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.9.5 Serengen Recent Development
11.10 BioDuro-Sundia
11.10.1 BioDuro-Sundia Company Details
11.10.2 BioDuro-Sundia Business Overview
11.10.3 BioDuro-Sundia DNA-encoded Chemical Libraries (DEL) Introduction
11.10.4 BioDuro-Sundia Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.10.5 BioDuro-Sundia Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis DNA-encoded Chemical Libraries (DEL) Introduction
11.11.4 Novartis Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.11.5 Novartis Recent Development
11.12 DyNAbind
11.12.1 DyNAbind Company Details
11.12.2 DyNAbind Business Overview
11.12.3 DyNAbind DNA-encoded Chemical Libraries (DEL) Introduction
11.12.4 DyNAbind Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.12.5 DyNAbind Recent Development
11.13 HitGen
11.13.1 HitGen Company Details
11.13.2 HitGen Business Overview
11.13.3 HitGen DNA-encoded Chemical Libraries (DEL) Introduction
11.13.4 HitGen Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.13.5 HitGen Recent Development
11.14 PharmaBlock Sciences
11.14.1 PharmaBlock Sciences Company Details
11.14.2 PharmaBlock Sciences Business Overview
11.14.3 PharmaBlock Sciences DNA-encoded Chemical Libraries (DEL) Introduction
11.14.4 PharmaBlock Sciences Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.14.5 PharmaBlock Sciences Recent Development
11.15 WuXi AppTec
11.15.1 WuXi AppTec Company Details
11.15.2 WuXi AppTec Business Overview
11.15.3 WuXi AppTec DNA-encoded Chemical Libraries (DEL) Introduction
11.15.4 WuXi AppTec Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.15.5 WuXi AppTec Recent Development
11.16 GenScript
11.16.1 GenScript Company Details
11.16.2 GenScript Business Overview
11.16.3 GenScript DNA-encoded Chemical Libraries (DEL) Introduction
11.16.4 GenScript Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.16.5 GenScript Recent Development
11.17 Pharmaron
11.17.1 Pharmaron Company Details
11.17.2 Pharmaron Business Overview
11.17.3 Pharmaron DNA-encoded Chemical Libraries (DEL) Introduction
11.17.4 Pharmaron Revenue in DNA-encoded Chemical Libraries (DEL) Business (2020-2025)
11.17.5 Pharmaron Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

HotSpot Therapeutics
X-Chem
Amgen
Life Chemicals
Elsevier
NovAliX
BOC Sciences
DECLTechnology
Serengen
BioDuro-Sundia
Novartis
DyNAbind
HitGen
PharmaBlock Sciences
WuXi AppTec
GenScript
Pharmaron

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂